Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches (Springer Theses) - Image 1

Price loading...

Springer Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches (Springer Theses)

Name: Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches (Springer Theses)
Brand: Springer

White

General Medical Issues

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

This thesis describes the authors’ pioneering efforts in the conceptualization and implementation of combined platinum-based immuno-chemotherapeutics, which represent a significant paradigm shift from the conventional approach of directly targeting cancer. The work described has opened up a rich and largely unexplored area for platinum-based drug design, and ultimately paves the way for superior immuno-chemotherapeutics with better clinical outcome for patients. Historically, the contribution of the immune system to chemotherapy outcomes has been neglected, as anticancer drugs were believed to be immunosuppressive. However, this has been challenged by contemporary evidence suggesting that many chemotherapeutics, including platinum-based agents, stimulate the innate and/or adaptive immune system and that these “secret allies” contribute tangibly to clinical outcomes. A multi-pronged immuno-chemotherapeutic approach not only shrinks tumors, but more importantly, reactivate dormant immuneresponses to malignancies, eliminating residual cancer cells.

Product Specifications

Brand: Springer
Colour: White
Format: hardcover
ASIN: 9811085935
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 29 June 2018
Listed Since: 31 January 2018

Barcode

No barcode data available

Springer Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches (Springer Theses)

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Rethinking Platinum Anticancer Drug Design: Towards Targeted and Immuno-chemotherapeutic Approaches (Springer Theses)

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Platinum-Based Drugs in Cancer Therapy (Cancer Drug Discovery and Development)

Springer - Immunotherapy of Cancer: An Innovative Treatment

Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Anti-Cancer N-Heterocyclic Carbene Complexes of Gold(III), Gold(I) and Platinum(II): Thiol “Switch-on” Fluorescent Probes, Thioredoxin Reductase ... Reticulum Targeting Agents (Springer Theses)

Targeted Cancer Immune Therapy

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Pharmaceutical Perspectives of Cancer Therapeutics

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

From Molecular to Modular Tumor Therapy:: Tumors are Reconstructible Communicatively Evolving Systems: 3 (The Tumor Microenvironment, 3)

Small Molecules for Cancer Treatment

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Molecular Targets in Cancer Therapy: Understanding Cellular Pathways for Therapeutic Interventions

Phase I Oncology Drug Development

Nano-formulation of Dietary Phytochemicals for Cancer Management

Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance

Medicinal Chemistry of Anticancer Drugs

Nanoparticle-Mediated Immunotherapy: 12 (Bioanalysis, 12)